Skip to content
value.today

ANI Pharmaceuticals, Inc.: insider trading

882 trades by 35 directors, officers and 10% owners since 2010, from their SEC Form 4 and 5 filings.

Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$14.0 M
49 sales by 11 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$2.4 M
12 sales

Insider buying and selling by month

Open-market purchases and sales by value, last three years.

-$35.6 M$0Nov 2023: bought $0 (0 trades), sold $2.9 M (7 trades)Nov 23Dec 2023: bought $0 (0 trades), sold $2.6 M (4 trades)Jan 2024: bought $0 (0 trades), sold $2.8 M (7 trades)Feb 2024: bought $0 (0 trades), sold $14 K (1 trades)Mar 2024: bought $0 (0 trades), sold $10.5 M (12 trades)Apr 2024: bought $0 (0 trades), sold $4.6 M (7 trades)AprMay 2024: bought $0 (0 trades), sold $5.9 M (9 trades)Jun 2024: bought $0 (0 trades), sold $4.8 M (8 trades)Jul 2024: bought $0 (0 trades), sold $4.5 M (6 trades)Aug 2024: bought $0 (0 trades), sold $15 K (1 trades)Sep 2024: bought $0 (0 trades), sold $14 K (1 trades)SepOct 2024: bought $0 (0 trades), sold $14 K (1 trades)Nov 2024: bought $0 (0 trades), sold $2.3 M (4 trades)Dec 2024: bought $0 (0 trades), sold $492 K (3 trades)Jan 2025: bought $0 (0 trades), sold $22 K (1 trades)Feb 2025: bought $0 (0 trades), sold $84 K (2 trades)FebMar 2025: bought $0 (0 trades), sold $531 K (5 trades)Apr 2025: bought $0 (0 trades), sold $28 K (1 trades)May 2025: bought $0 (0 trades), sold $373 K (4 trades)Jun 2025: bought $0 (0 trades), sold $25 K (1 trades)Jul 2025: bought $0 (0 trades), sold $26 K (1 trades)JulAug 2025: bought $0 (0 trades), sold $35.6 M (18 trades)Sep 2025: bought $0 (0 trades), sold $830 K (3 trades)Oct 2025: bought $0 (0 trades), sold $36 K (1 trades)Nov 2025: bought $0 (0 trades), sold $2.1 M (4 trades)Dec 2025: bought $0 (0 trades), sold $313 K (3 trades)DecJan 2026: bought $0 (0 trades), sold $42 K (1 trades)Feb 2026: bought $0 (0 trades), sold $1.3 M (5 trades)Mar 2026: bought $0 (0 trades), sold $2.7 M (12 trades)Apr 2026: bought $0 (0 trades), sold $39 K (1 trades)May 2026: bought $0 (0 trades), sold $5.7 M (6 trades)MayJun 2026: bought $0 (0 trades), sold $707 K (4 trades)Jul 2026: bought $0 (0 trades), sold $558 K (3 trades)Aug 2026: bought $0 (0 trades), sold $890 K (4 trades)Sep 2026: bought $0 (0 trades), sold $698 K (4 trades)Oct 2026: bought $0 (0 trades), sold $633 K (3 trades)OctNov 2026: bought $0 (0 trades), sold $420 K (3 trades)
Bought (open market)Sold (open market)Hover a month for the totals

Insiders (35)

Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.

ANI Pharmaceuticals, Inc. insiders
InsiderShares owned directlyBought, 12 mSold, 12 mLatest trade
Nikhil LalwaniPRESIDENT & CEO, Director328,289—$5.8 M
Meredith CookSR. VP, GENERAL COUNSEL & SEC.72,924—$455 K
Stephen P. CareySVP & CFO166,143—$2.2 M
Jeanne ThomaDirector26,762—$72 K
Henry O. GosebruchDirector6,662——
Ori GutwergSVP, GENERICS75,534—$621 K
Thomas HaugheyDirector38,878—$162 K
Antonio R. PeraDirector27,017——
Matthew J. LeonardDirector11,221——
Renee P. TannenbaumDirector29,514—$146 K
Patrick D. WalshDirector38,432—$1.6 M
Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDS38,271—$394 K
Christopher MutzHEAD OF RARE DISEASE91,309—$1.6 M
Krista DavisSVP, CHIEF HR OFFICER51,946—$919 K
Chad GassertSVP - CORP. DEV. & STRATEGY74,916——
Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, Director101,056——
James G. MarkenSVP OPS & PROD DEV117,829——
Meridian Venture Partners II LP10% owner1.82 M——
David NashDirector38,561——
Meridian Venture Partners II GP, L.P.10% owner2.02 M——
Robert E. Brown Jr.Director49,021——
Robert W. SchrepferSVP - NEW BUS DEV & SPEC SALES87,477——
Arthur PrzybylPresident and CEO, Director190,309——
Thomas A. PennDirector14,301——
Tracy MarshbanksDirector11,110——
Fred HolubowDirector14,811——
Daniel RaynorDirector11,110——
Charlotte C. ArnoldVice President and CFO54,298——
Peter A. LankauDirector2,500——
Ross J. ManganoDirector26,914——
Robert J. JamnickVP, Quality & Product Develop.48,118——
Edward C. Rosenow IIIDirector20,540——
Louis W. SullivanDirector47,898——
Philip B. DonenbergSr. VP of Finance, CFO & Secy44,322——
Stephen M. SimesVice Chairman, President & CEO, Director———

Trades#

The newest 300 trades.

ANI Pharmaceuticals, Inc.: insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Nikhil LalwaniPRESIDENT & CEO, DirectorSell10b5-1 plan-4,082$71.16$290 K328,289Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorSell10b5-1 plan-1,318$71.40$94 K332,371Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-500$70.80$35 K72,924Form 4
filed Stephen P. CareySVP & CFOSell10b5-1 plan-2,850$72.87$208 K166,143Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorSell10b5-1 plan-5,400$71.89$388 K333,689Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-500$73.59$37 K73,424Form 4
filed Stephen P. CareySVP & CFOSell10b5-1 plan-2,850$73.00$208 K168,993Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorSell10b5-1 plan-5,400$71.00$383 K339,089Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-500$70.79$35 K73,924Form 4
filed Jeanne ThomaDirectorSell10b5-1 plan-1,000$71.53$72 K26,762Form 4
filed Stephen P. CareySVP & CFOSell10b5-1 plan-2,850$72.80$207 K171,843Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorSell10b5-1 plan-5,400$74.30$401 K344,489Form 4
filed Henry O. GosebruchDirectorGrant or award+6,662——6,662Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-500$75.48$38 K74,424Form 4
filed Ori GutwergSVP, GENERICSSell-3,162$77.00$243 K75,534Form 4
filed Stephen P. CareySVP & CFOSell10b5-1 plan-2,850$81.36$232 K174,693Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Shares withheld for tax-2,466$79.20$195 K74,924Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-500$81.84$41 K77,390Form 4
filed Stephen P. CareySVP & CFOOption exercise10b5-1 plan+3,313$49.51$164 K180,856Form 4
filed Stephen P. CareySVP & CFOSell10b5-1 plan-3,313$86.00$285 K177,543Form 4
filed Stephen P. CareySVP & CFOSell10b5-1 plan-2,850$84.12$240 K177,543Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-500$82.03$41 K77,890Form 4
filed Thomas HaugheyDirectorSell10b5-1 plan-2,000$80.88$162 K38,878Form 4
filed Stephen P. CareySVP & CFOOption exercise10b5-1 plan+3,312$49.51$164 K183,705Form 4
filed Stephen P. CareySVP & CFOSell10b5-1 plan-3,312$80.00$265 K180,393Form 4
filed Thomas HaugheyDirectorGrant or award10b5-1 plan+4,357——40,878Form 4
filed Matthew J. LeonardDirectorGrant or award+4,357——11,221Form 4
filed Renee P. TannenbaumDirectorGrant or award+4,357——29,514Form 4
filed Jeanne ThomaDirectorGrant or award+4,357——27,762Form 4
filed Antonio R. PeraDirectorGrant or award+4,357——27,017Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-500$78.16$39 K78,390Form 4
filed Patrick D. WalshDirectorSell-10,000$80.63$806 K38,432Form 4
filed Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDSSell-459$79.21$36 K38,271Form 4
filed Ori GutwergSVP, GENERICSSell-2,772$79.50$220 K78,696Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorSell-55,000$77.57$4.3 M349,889Form 4
filed Patrick D. WalshDirectorSell-3,973$80.75$321 K48,432Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-500$77.95$39 K78,890Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-500$72.62$36 K79,390Form 4
filed Christopher MutzHEAD OF RARE DISEASESell10b5-1 plan-3,162$71.64$227 K91,309Form 4
filed Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDSSell-4,772$74.91$357 K38,730Form 4
filed Krista DavisSVP, CHIEF HR OFFICERSell10b5-1 plan-5,087$74.13$377 K51,946Form 4
filed Christopher MutzHEAD OF RARE DISEASESell10b5-1 plan-3,602$74.18$267 K94,471Form 4
filed Stephen P. CareySVP & CFOShares withheld for tax-5,150$74.04$381 K180,393Form 4
filed Ori GutwergSVP, GENERICSShares withheld for tax-3,314$74.04$245 K81,468Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorShares withheld for tax-17,060$74.04$1.3 M404,889Form 4
filed Christopher MutzHEAD OF RARE DISEASEShares withheld for tax10b5-1 plan-3,314$74.04$245 K98,073Form 4
filed Christopher MutzHEAD OF RARE DISEASESell10b5-1 plan-2,121$74.22$157 K101,387Form 4
filed Krista DavisSVP, CHIEF HR OFFICERSell10b5-1 plan-1,485$75.00$111 K57,033Form 4
filed Stephen P. CareySVP & CFOOption exercise+3,312$49.51$164 K192,855Form 4
filed Stephen P. CareySVP & CFOSell-3,312$75.42$250 K189,543Form 4
filed Stephen P. CareySVP & CFOSell-4,000$75.56$302 K185,543Form 4
filed Ori GutwergSVP, GENERICSSell-2,060$76.50$158 K84,782Form 4
filed Patrick D. WalshDirectorSell-6,000$74.23$445 K52,405Form 4
filed Christopher MutzHEAD OF RARE DISEASESell10b5-1 plan-417$74.00$31 K103,508Form 4
filed Stephen P. CareySVP & CFOShares withheld for tax-2,773$73.90$205 K189,543Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYShares withheld for tax-2,221$73.90$164 K74,916Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Shares withheld for tax-1,555$73.90$115 K79,890Form 4
filed Krista DavisSVP, CHIEF HR OFFICERShares withheld for tax-1,555$73.90$115 K58,518Form 4
filed Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDSShares withheld for tax-628$73.90$46 K43,502Form 4
filed Ori GutwergSVP, GENERICSShares withheld for tax-2,221$73.90$164 K86,842Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorShares withheld for tax-12,217$73.90$903 K421,949Form 4
filed Christopher MutzHEAD OF RARE DISEASEShares withheld for tax-2,221$73.90$164 K103,925Form 4
filed Stephen P. CareySVP & CFOGrant or award+22,233$77.15$1.7 M192,316Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorGrant or award+11,116$77.15$858 K101,056Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYGrant or award+11,116$77.15$858 K77,137Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Grant or award+13,895$77.15$1.1 M81,445Form 4
filed Krista DavisSVP, CHIEF HR OFFICERGrant or award+10,810$77.15$834 K60,073Form 4
filed Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDSGrant or award+6,021$77.15$465 K44,130Form 4
filed Ori GutwergSVP, GENERICSGrant or award+12,969$77.15$1.0 M89,063Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorGrant or award+75,592$77.15$5.8 M434,166Form 4
filed Christopher MutzHEAD OF RARE DISEASEGrant or award+21,306$77.15$1.6 M106,146Form 4
filed Christopher MutzHEAD OF RARE DISEASESell10b5-1 plan-5,323$78.02$415 K84,840Form 4
filed Krista DavisSVP, CHIEF HR OFFICERSell10b5-1 plan-1,730$77.99$135 K49,263Form 4
filed Krista DavisSVP, CHIEF HR OFFICERSell10b5-1 plan-2,084$77.53$162 K50,993Form 4
filed Stephen P. CareySVP & CFOShares withheld for tax-2,448$77.36$189 K170,083Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYShares withheld for tax-1,717$77.36$133 K66,021Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorShares withheld for tax-10,298$77.36$797 K358,574Form 4
filed Krista DavisSVP, CHIEF HR OFFICERShares withheld for tax-1,290$77.36$100 K53,077Form 4
filed Ori GutwergSVP, GENERICSShares withheld for tax-1,888$77.36$146 K76,094Form 4
filed Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDSShares withheld for tax-485$77.36$38 K38,109Form 4
filed Christopher MutzHEAD OF RARE DISEASEShares withheld for tax10b5-1 plan-2,403$77.36$186 K90,163Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Shares withheld for tax10b5-1 plan-1,779$77.36$138 K67,550Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-500$76.80$38 K69,329Form 4
filed Stephen P. CareySVP & CFOShares withheld for tax-2,829$76.70$217 K172,531Form 4
filed Christopher MutzHEAD OF RARE DISEASEShares withheld for tax10b5-1 plan-3,173$76.70$243 K99,598Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYShares withheld for tax-1,608$76.70$123 K67,738Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorShares withheld for tax-11,688$76.70$896 K368,872Form 4
filed Krista DavisSVP, CHIEF HR OFFICERShares withheld for tax-1,180$76.70$91 K54,367Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Shares withheld for tax10b5-1 plan-1,534$76.70$118 K69,829Form 4
filed Ori GutwergSVP, GENERICSShares withheld for tax-1,775$76.70$136 K77,982Form 4
filed Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDSShares withheld for tax-566$76.70$43 K38,594Form 4
filed Christopher MutzHEAD OF RARE DISEASESell10b5-1 plan-7,032$76.55$538 K92,566Form 4
filed Ori GutwergSVP, GENERICSShares withheld for tax-4,267$76.25$325 K79,757Form 4
filed Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDSShares withheld for tax-1,762$76.25$134 K39,160Form 4
filed Christopher MutzHEAD OF RARE DISEASEShares withheld for tax-4,546$76.25$347 K102,771Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorShares withheld for tax-2,898$76.25$221 K89,940Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorShares withheld for tax-30,659$76.25$2.3 M380,560Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Shares withheld for tax-3,011$76.25$230 K71,363Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYShares withheld for tax-4,269$76.25$326 K69,346Form 4
filed Stephen P. CareySVP & CFOShares withheld for tax-5,503$76.25$420 K175,360Form 4
filed Krista DavisSVP, CHIEF HR OFFICERShares withheld for tax-3,017$76.25$230 K55,547Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-500$84.33$42 K74,374Form 4
filed Krista DavisSVP, CHIEF HR OFFICERSell10b5-1 plan-1,622$82.40$134 K58,564Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-400$82.32$33 K74,874Form 4
filed Renee P. TannenbaumDirectorSell-1,800$81.15$146 K25,157Form 4
filed Patrick D. WalshDirectorSell-8,643$86.88$751 K61,405Form 4
filed Patrick D. WalshDirectorGift-3,000——58,405Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-400$87.27$35 K75,274Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYSellindirect-94$88.00$8 K158,490Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYSellindirect-14,642$89.07$1.3 M158,584Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-400$90.09$36 K75,674Form 4
filed Krista DavisSVP, CHIEF HR OFFICERSell10b5-1 plan-1,000$98.04$98 K60,186Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-400$98.42$39 K76,074Form 4
filed Krista DavisSVP, CHIEF HR OFFICERShares withheld for tax-1,710$97.71$167 K61,186Form 4
filed Antonio R. PeraDirectorSell-7,292$94.94$692 K22,660Form 4
filed Matthew J. LeonardDirectorSell-2,528$90.62$229 K6,864Form 4
filed Krista DavisSVP, CHIEF HR OFFICERSell-1,763$91.10$161 K62,896Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSellindirect-52,988$90.44$4.8 M431,920Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSellindirect-47,012$90.27$4.2 M484,908Form 4
filed Antonio R. PeraDirectorSell-5,421$89.73$486 K29,952Form 4
filed Jeanne ThomaDirectorSell-6,865$89.76$616 K38,080Form 4
filed Jeanne ThomaDirectorSell-14,675$88.87$1.3 M23,405Form 4
filed Matthew J. LeonardDirectorSell-6,937$88.17$612 K9,392Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYSellindirect-20,000$86.97$1.7 M173,226Form 4
filed Patrick D. WalshDirectorSell-9,000$89.05$801 K70,048Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSellindirect-52,990$87.15$4.6 M531,920Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSellindirect-47,010$89.48$4.2 M584,910Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-400$88.87$36 K76,474Form 4
filed Ori GutwergSVP, GENERICSSell-5,873$86.53$508 K84,024Form 4
filed Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDSSell-4,975$85.71$426 K40,794Form 4
filed Thomas HaugheyDirectorSell-19,341$85.93$1.7 M36,521Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorSell-56,960$85.93$4.9 M411,219Form 4
filed Stephen P. CareySVP & CFOOption exercise+50,000$46.49$2.3 M230,863Form 4
filed Stephen P. CareySVP & CFOSell-50,000$86.07$4.3 M180,863Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Shares withheld for tax-2,071$66.30$137 K76,874Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-400$64.88$26 K78,945Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-400$61.37$25 K79,345Form 4
filed Antonio R. PeraDirectorGrant or award+4,336——35,373Form 4
filed Renee P. TannenbaumDirectorGrant or award+4,336——26,957Form 4
filed Jeanne ThomaDirectorGrant or award+4,336——44,945Form 4
filed Matthew J. LeonardDirectorGrant or award+4,336——16,329Form 4
filed Patrick D. WalshDirectorGrant or award+4,336——79,048Form 4
filed Thomas HaugheyDirectorGrant or award+4,336——55,862Form 4
filed Ori GutwergSVP, GENERICSSell-881$60.07$53 K89,897Form 4
filed Christopher MutzHEAD OF RARE DISEASESell-4,000$60.45$242 K107,317Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-400$62.20$25 K79,745Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-700$76.83$54 K631,920Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-400$68.96$28 K80,145Form 4
filed Stephen P. CareySVP & CFOShares withheld for tax-6,210$64.26$399 K180,863Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorShares withheld for tax-17,455$64.26$1.1 M468,179Form 4
filed Krista DavisSVP, CHIEF HR OFFICERSell10b5-1 plan-1,866$65.00$121 K64,659Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-400$63.33$25 K80,545Form 4
filed Ori GutwergSVP, GENERICSShares withheld for tax-3,314$60.62$201 K90,778Form 4
filed Stephen P. CareySVP & CFOShares withheld for tax-5,150$60.62$312 K187,073Form 4
filed Christopher MutzHEAD OF RARE DISEASEShares withheld for tax-2,874$60.62$174 K111,317Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorShares withheld for tax-17,060$60.62$1.0 M485,634Form 4
filed Krista DavisSVP, CHIEF HR OFFICERSell10b5-1 plan-1,000$60.86$61 K66,525Form 4
filed Ori GutwergSVP, GENERICSOption exercise+300$31.49$9 K99,476Form 4
filed Ori GutwergSVP, GENERICSSell-300$60.03$18 K99,176Form 4
filed Ori GutwergSVP, GENERICSSell-5,084$60.00$305 K94,092Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorShares withheld for tax-12,216$61.89$756 K502,694Form 4
filed Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDSShares withheld for tax-627$61.89$39 K45,465Form 4
filed Stephen P. CareySVP & CFOShares withheld for tax-1,861$61.89$115 K192,223Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Shares withheld for tax-1,099$61.89$68 K80,945Form 4
filed Christopher MutzHEAD OF RARE DISEASEShares withheld for tax-1,275$61.89$79 K114,191Form 4
filed Ori GutwergSVP, GENERICSShares withheld for tax-1,570$61.89$97 K99,176Form 4
filed Krista DavisSVP, CHIEF HR OFFICERShares withheld for tax-1,099$61.89$68 K67,525Form 4
filed Krista DavisSVP, CHIEF HR OFFICERSell10b5-1 plan-1,000$60.20$60 K68,624Form 4
filed Christopher MutzHEAD OF RARE DISEASEShares withheld for tax-1,184$58.92$70 K115,466Form 4
filed Ori GutwergSVP, GENERICSShares withheld for tax-1,167$58.92$69 K100,746Form 4
filed Christopher MutzHEAD OF RARE DISEASEShares withheld for tax-1,473$58.92$87 K116,650Form 4
filed Ori GutwergSVP, GENERICSShares withheld for tax-1,426$58.92$84 K101,913Form 4
filed Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDSShares withheld for tax-582$58.92$34 K46,092Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorShares withheld for tax-7,799$58.92$460 K514,910Form 4
filed Krista DavisSVP, CHIEF HR OFFICERShares withheld for tax-1,196$58.92$70 K69,624Form 4
filed Stephen P. CareySVP & CFOShares withheld for tax-1,730$58.92$102 K194,084Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Shares withheld for tax10b5-1 plan-1,434$58.92$84 K82,044Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-400$59.54$24 K83,478Form 4
filed Krista DavisSVP, CHIEF HR OFFICERGrant or award+13,057——62,116Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Grant or award10b5-1 plan+16,974——72,562Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorGrant or award+14,362——83,014Form 4
filed Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDSGrant or award+7,834——41,452Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorGrant or award+91,399——461,777Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYGrant or award+14,362——64,041Form 4
filed Stephen P. CareySVP & CFOGrant or award+24,808——179,276Form 4
filed Ori GutwergSVP, GENERICSGrant or award+15,668——92,895Form 4
filed Christopher MutzHEAD OF RARE DISEASEGrant or award+24,808——101,585Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorGrant or award+60,932——522,709Form 4
filed Krista DavisSVP, CHIEF HR OFFICERGrant or award+8,704——70,820Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorGrant or award+9,574——92,588Form 4
filed Stephen P. CareySVP & CFOGrant or award+16,538——195,814Form 4
filed Christopher MutzHEAD OF RARE DISEASEGrant or award+16,538——118,123Form 4
filed Ori GutwergSVP, GENERICSGrant or award+10,444——103,339Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYGrant or award+9,574——73,615Form 4
filed Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDSGrant or award+5,222——46,674Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Grant or award10b5-1 plan+11,316——83,878Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-400$53.92$22 K55,588Form 4
filed Stephen P. CareySVP & CFOSell-7,500$55.79$418 K154,468Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-250$56.24$14 K55,988Form 4
filed Krista DavisSVP, CHIEF HR OFFICERSell10b5-1 plan-1,000$60.00$60 K49,059Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorOption exercise+30,000$29.00$870 K403,859Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorSell-30,000$57.95$1.7 M373,859Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorSell-3,481$58.30$203 K370,378Form 4
filed Christopher MutzHEAD OF RARE DISEASESell-6,500$57.70$375 K76,777Form 4
filed Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDSShares withheld for tax-867$56.58$49 K33,169Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-250$61.36$15 K56,238Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-250$57.19$14 K56,488Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-250$56.82$14 K56,738Form 4
filed Krista DavisSVP, CHIEF HR OFFICERShares withheld for tax-1,486$56.15$83 K50,059Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorShares withheld for tax-3,646$60.51$221 K373,859Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-250$59.62$15 K56,988Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-2,743$62.00$170 K632,620Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Shares withheld for tax-1,743$61.35$107 K57,238Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-14,257$63.16$900 K635,363Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-22,000$64.27$1.4 M649,620Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-11,000$63.38$697 K671,620Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-250$64.91$16 K58,981Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYSell10b5-1 plan · indirect-20,000$63.44$1.3 M193,226Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-20,000$58.90$1.2 M682,620Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-11,447$59.86$685 K702,620Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-10,607$60.76$644 K714,067Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-7,946$61.41$488 K724,674Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-250$63.80$16 K59,231Form 4
filed James G. MarkenSVP OPS & PROD DEVOption exercise+7,250$49.51$359 K123,616Form 4
filed James G. MarkenSVP OPS & PROD DEVOption exercise+5,300$57.06$302 K128,916Form 4
filed James G. MarkenSVP OPS & PROD DEVShares withheld for tax-11,087$67.70$751 K117,829Form 4
filed Ori GutwergSVP, GENERICSSell-2,985$67.00$200 K77,227Form 4
filed Stephen P. CareySVP & CFOSell-5,000$63.58$318 K161,968Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYSell10b5-1 plan · indirect-20,000$64.41$1.3 M213,226Form 4
filed Jeanne ThomaDirectorGrant or award+4,410——40,609Form 4
filed Matthew J. LeonardDirectorGrant or award+4,410——11,993Form 4
filed Renee P. TannenbaumDirectorGrant or award+4,410——22,621Form 4
filed Antonio R. PeraDirectorGrant or award+4,410——31,037Form 4
filed Patrick D. WalshDirectorGrant or award+4,410——74,712Form 4
filed Thomas HaugheyDirectorGrant or award+4,410——51,526Form 4
filed Christopher MutzHEAD OF RARE DISEASESell-2,000$61.61$123 K83,277Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-12,855$61.81$795 K732,620Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-5,836$62.09$362 K745,475Form 4
filed Renee P. TannenbaumDirectorSell-2,000$63.87$128 K18,211Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-16,459$63.84$1.1 M751,311Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-14,850$65.86$978 K767,770Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorSell-16,669$66.10$1.1 M377,505Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-250$67.69$17 K59,481Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYSell10b5-1 plan · indirect-20,000$66.62$1.3 M233,226Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-16,809$65.17$1.1 M782,620Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-10,423$64.98$677 K799,429Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-9,520$65.40$623 K809,852Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-5,834$66.20$386 K819,372Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-7,414$66.33$492 K825,206Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-250$67.79$17 K59,731Form 4
filed Stephen P. CareySVP & CFOShares withheld for tax-4,534$66.96$304 K166,968Form 4
filed James G. MarkenSVP OPS & PROD DEVShares withheld for tax-2,799$66.96$187 K116,006Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYSell10b5-1 plan · indirect-20,000$67.25$1.3 M253,226Form 4
filed James G. MarkenSVP OPS & PROD DEVShares withheld for tax-3,653$69.58$254 K118,805Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorShares withheld for tax-17,455$69.58$1.2 M394,174Form 4
filed Stephen P. CareySVP & CFOShares withheld for tax-6,210$69.58$432 K171,502Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Sell10b5-1 plan-250$66.54$17 K59,981Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYSell10b5-1 plan · indirect-20,000$65.81$1.3 M273,226Form 4
filed Stephen P. CareySVP & CFOSell-7,787$65.55$510 K177,712Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-10,000$67.17$672 K832,620Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorSell-16,292$67.13$1.1 M411,629Form 4
filed Stephen P. CareySVP & CFOShares withheld for tax-4,216$66.71$281 K185,499Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorShares withheld for tax-17,060$66.71$1.1 M427,921Form 4
filed Christopher MutzHEAD OF RARE DISEASEShares withheld for tax-2,110$66.71$141 K85,277Form 4
filed James G. MarkenSVP OPS & PROD DEVSell-24,338$66.37$1.6 M124,492Form 4
filed Ori GutwergSVP, GENERICSShares withheld for tax-2,494$66.71$166 K80,212Form 4
filed James G. MarkenSVP OPS & PROD DEVShares withheld for tax-2,034$66.71$136 K122,458Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-15,085$66.35$1.0 M842,620Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorSell-28,965$65.52$1.9 M444,981Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-14,822$65.47$970 K857,705Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorSell10b5-1 plan · indirect-10,093$65.35$660 K872,527Form 4
filed Christopher MutzHEAD OF RARE DISEASESell-5,000$66.00$330 K87,387Form 4
filed Antonio R. PeraDirectorSell-7,000$65.20$456 K26,627Form 4
filed Christopher MutzHEAD OF RARE DISEASEShares withheld for tax-1,275$67.67$86 K92,387Form 4
filed Ori GutwergSVP, GENERICSShares withheld for tax-1,570$67.67$106 K82,706Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYShares withheld for tax-1,635$67.67$111 K49,679Form 4
filed Krista DavisSVP, CHIEF HR OFFICERShares withheld for tax-1,173$67.67$79 K51,545Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorShares withheld for tax-1,122$67.67$76 K68,652Form 4
filed Stephen P. CareySVP & CFOShares withheld for tax-1,914$67.67$130 K189,715Form 4
filed James G. MarkenSVP OPS & PROD DEVShares withheld for tax-1,058$67.67$72 K148,830Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorShares withheld for tax-10,014$67.67$678 K473,946Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Shares withheld for tax-1,173$67.67$79 K60,231Form 4
filed Christopher MutzHEAD OF RARE DISEASEShares withheld for tax-1,261$57.55$73 K93,662Form 4
filed Ori GutwergSVP, GENERICSShares withheld for tax-1,244$57.55$72 K84,276Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYGrant or award+13,421——42,368Form 4
filed Krista DavisSVP, CHIEF HR OFFICERGrant or award+12,079——44,666Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorGrant or award+13,421——60,828Form 4
filed Nikhil LalwaniPRESIDENT & CEO, DirectorGrant or award+80,530——430,274Form 4
filed Stephen P. CareySVP & CFOGrant or award+21,474——177,313Form 4
filed James G. MarkenSVP OPS & PROD DEVGrant or award+10,066——143,178Form 4
filed Ori GutwergSVP, GENERICSGrant or award+14,763——75,678Form 4
filed Christopher MutzHEAD OF RARE DISEASEGrant or award+18,790——82,397Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Grant or award+14,763——51,562Form 4
filed Krista DavisSVP, CHIEF HR OFFICERGrant or award+8,052——52,718Form 4
filed Chad GassertSVP - CORP. DEV. & STRATEGYGrant or award+8,946——51,314Form 4
filed Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS, DirectorGrant or award+8,946——69,774Form 4
filed Stephen P. CareySVP & CFOGrant or award+14,316——191,629Form 4
filed Ori GutwergSVP, GENERICSGrant or award+9,842——85,520Form 4
filed Meredith CookSR. VP, GENERAL COUNSEL & SEC.Grant or award+9,842——61,404Form 4
filed Christopher MutzHEAD OF RARE DISEASEGrant or award+12,526——94,923Form 4

Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice